ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects of Curcuminoids and Surfactant-Formulated Curcumin on Chemo-Resistant Colorectal Cancer

Wan, Chunping*; Ma, Qinge; Anderson, Samantha; Zhang, Qi-Hui; Zhang, Chun-Feng; Wang, Angela H.; Bell, Emma; Hou, Lifei; Yuan, Chun-Su; Wang, Chong-Zhi重庆大学; 1
AMERICAN JOURNAL OF CHINESE MEDICINE2023-7-19DOI: 10.1142/S0192415X23500714
10阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is a leading cause of cancer-related death in the United States, and chronic gut inflammation is a risk factor for CRC initiation and development. Curcuma longa L., or turmeric, has become one of the most studied herbal medicines in recent years due to its anticancer potentials. It is generally accepted that the major component in turmeric is curcuminoids, and the active constituent in curcuminoids is curcumin. However, unprocessed curcumin is characterized by poor water solubility, which means low bioavailability in humans. To increase the bioavailability of curcumin, in this study, we utilized a novel surfactant-formulated curcumin (CuminUP60 (R)) and evaluated its CRC chemopreventive activities. Compared with the chemo-sensitive CRC cell line HCT-116, the management of the CRC SW-480 cell line is a challenge, since the latter is chemo-resistant. In other words, these cancer cells resist the effects of the chemotherapy. Using the newly formulated CuminUP60 (R) water solution, this study demonstrated its strong antiproliferative effects on the SW-480 cells in a dose- and time-dependent manner. This new formulation induced early apoptosis and arrested the cell cycle in the G2/M phase via the upregulation of cyclin B1. We also observed that this new formulation possessed inhibitory effects on Th17 cell differentiation, which regulates the body's immune response against gut malignancies. In summary, our results exhibited a potential clinical utility of the surfactant-formulated curcumin in chemo-resistant colorectal cancer management.

学科与关键词

关键词
TurmericCurcuminoidsCurcuminSurfactant-FormulationChemo-Resistant Colorectal CancerApoptosisCell CycleCyclin B1Adaptive ImmunityTh17
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
AMERICAN JOURNAL OF CHINESE MEDICINE
发表日期
2023-07-19
DOI
10.1142/S0192415X23500714
语言
ENGLISH
成果收录
SCIE
资助标注
Tang Foundation for the Research of Traditional Chinese Medicine

作者

  • W

    Wan, Chunping (通讯) (第一作者)

    1 · yunnan univ tradit chinese med

  • M

    Ma, Qinge

    jiangxi univ tradit chinese med

查看全部 10 位作者收起作者
  • A

    Anderson, Samantha

  • Z

    Zhang, Qi-Hui

    chongqing univ

  • Z

    Zhang, Chun-Feng

    china pharmaceut univ

  • W

    Wang, Angela H.

  • B

    Bell, Emma

  • H

    Hou, Lifei

  • Y

    Yuan, Chun-Su

  • W

    Wang, Chong-Zhi

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417